BioLife Solutions, Inc. (BLFS) Financials

$26.15

south_east
-$0.3 (-1.13%)
Day's range
$25.73
Day's range
$26.74

BLFS Income statement / Annual

Last year (2023), BioLife Solutions, Inc.'s total revenue was $143.27 M, a decrease of 11.43% from the previous year. In 2023, BioLife Solutions, Inc.'s net income was -$66.43 M. See BioLife Solutions, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 01/31/2015
Operating Revenue $143.27 M $161.76 M $119.16 M $48.09 M $27.37 M $19.74 M $11.02 M $8.23 M $6.45 M $6.19 M
Cost of Revenue $96.52 M $107.94 M $81.41 M $20.65 M $8.86 M $6.22 M $4.28 M $3.45 M $2.63 M $3.16 M
Gross Profit $46.75 M $53.82 M $37.75 M $27.44 M $18.51 M $13.53 M $6.75 M $4.78 M $3.81 M $3.04 M
Gross Profit Ratio 0.33 0.33 0.32 0.57 0.68 0.69 0.61 0.58 0.59 0.49
Research and Development Expenses $18.80 M $14.80 M $11.82 M $6.72 M $4.12 M $1.30 M $1.19 M $2.03 M $1.38 M $871,100.00
General & Administrative Expenses $55.73 M $47.67 M $34.10 M $14.61 M $9.08 M $5.95 M $4.52 M $4.59 M $4.87 M $3.97 M
Selling & Marketing Expenses $24.58 M $21.57 M $14.00 M $6.41 M $4.98 M $2.62 M $2.09 M $3.01 M $2.58 M $1.33 M
Selling, General & Administrative Expenses $80.31 M $69.24 M $48.09 M $21.02 M $14.05 M $8.57 M $6.61 M $7.60 M $7.45 M $5.30 M
Other Expenses $18.47 M $9.70 M $8.20 M $3.03 M $9.86 M $276,000.00 -$454,000.00 -$404,000.00 $0.00 -$165,105.00
Operating Expenses $117.58 M $93.73 M $68.11 M $30.77 M $18.17 M $9.86 M $7.80 M $9.63 M $8.83 M $6.17 M
Cost And Expenses $214.10 M $201.67 M $149.52 M $51.42 M $27.03 M $16.08 M $12.08 M $13.08 M $11.47 M $9.33 M
Interest Income $0.00 $687,000.00 $485,000.00 $58,000.00 $506,000.00 $281,000.00 $350.00 $2,420.00 $21,753.00 $20,825.00
Interest Expense $1.81 M $687,000.00 $485,000.00 $18,000.00 $5,000.00 $5,000.00 $190,069.00 $100,000.00 $21,753.00 $177,308.00
Depreciation & Amortization $12.30 M $19.96 M $14.92 M $5.81 M $2.31 M $338,000.00 $339,000.00 $368,102.00 $343,218.00 $258,119.00
EBITDA -$45.24 M -$23.19 M -$17.78 M $1.07 M -$884,000.00 -$24.66 M -$1.79 M -$7.35 M -$4.67 M -$2.85 M
EBITDA Ratio -0.32 -0.18 -0.2 -0.06 0.04 0.19 -0.1 -0.25 -0.78 -0.51
Operating Income Ratio -0.49 -0.25 -0.25 -0.07 -0.03 0.19 -0.1 -0.59 -0.78 -0.51
Total Other Income/Expenses Net $4.57 M $714,000.00 $1.34 M $4.98 M -$2.98 M -$28.67 M -$1.46 M -$3.19 M $21,753.00 -$165,105.00
Income Before Tax -$66.26 M -$144.83 M -$28.69 M -$597,000.00 $9.52 M $3.27 M -$2.52 M -$8.04 M -$5.00 M -$3.30 M
Income Before Tax Ratio -0.46 -0.9 -0.24 -0.01 0.35 0.17 -0.23 -0.98 -0.77 -0.53
Income Tax Expense $169,000.00 -$5.02 M -$20.31 M -$3.26 M -$1.54 M $396,000.00 $1.46 M $1.62 M -$824,946.00 -$87,445.00
Net Income -$66.43 M -$139.81 M -$8.38 M $2.67 M $11.06 M $3.27 M -$2.52 M -$6.88 M -$4.21 M -$3.22 M
Net Income Ratio -0.46 -0.86 -0.07 0.06 0.4 0.17 -0.23 -0.84 -0.65 -0.52
EPS -1.52 -3.29 -0.22 0.0977 -0.0852 0.2 -0.19 -0.54 -0.35 -0.31
EPS Diluted -1.52 -3.29 -0.22 0.0977 -0.0852 0.2 -0.19 -0.54 -0.35 -0.31
Weighted Average Shares Out $43.72 M $42.48 M $38.50 M $27.31 M $19.46 M $16.26 M $13.26 M $12.64 M $12.18 M $10.45 M
Weighted Average Shares Out Diluted $43.72 M $42.48 M $38.50 M $27.31 M $19.46 M $16.26 M $13.26 M $12.64 M $12.18 M $10.45 M
Link